Literature DB >> 26773315

Curcumin prevents paracetamol-induced liver mitochondrial alterations.

Luis Fernando Granados-Castro1, Daniela Sarai Rodríguez-Rangel1, Berenice Fernández-Rojas1, Juan Carlos León-Contreras2, Rogelio Hernández-Pando2, Omar Noel Medina-Campos1, Dianelena Eugenio-Pérez1, Enrique Pinzón3, José Pedraza-Chaverri1.   

Abstract

OBJECTIVE: In the present study was evaluated if curcumin is able to attenuate paracetamol (PCM)-induced mitochondrial alterations in liver of mice.
METHODS: Mice (n = 5-6/group) received curcumin (35, 50 or 100 mg/kg bw) 90 min before PCM injection (350 mg/kg bw). Plasma activity of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) was measured; histological analyses were done; and measurement of mitochondrial oxygen consumption, mitochondrial membrane potential, ATP synthesis, aconitase activity and activity of respiratory complexes was carried out. KEY
FINDINGS: Curcumin prevented in a dose-dependent manner PCM-induced liver damage. Curcumin (100 mg/kg) attenuated PCM-induced liver histological damage (damaged hepatocytes from 28.3 ± 7.7 to 8.3 ± 0.7%) and increment in plasma ALT (from 2300 ± 150 to 690 ± 28 U/l) and AST (from 1603 ± 43 to 379 ± 22 U/l) activity. Moreover, curcumin attenuated the decrease in oxygen consumption using either succinate or malate/glutamate as substrates (evaluated by state 3, respiratory control ratio, uncoupled respiration and adenosine diphosphate/oxygen ratio), in membrane potential, in ATP synthesis, in aconitase activity and in the activity of respiratory complexes I, III and IV.
CONCLUSIONS: These results indicate that the protective effect of curcumin in PCM-induced hepatotoxicity is associated with attenuation of mitochondrial dysfunction.
© 2016 Royal Pharmaceutical Society.

Entities:  

Keywords:  aconitase; adenosine triphosphate synthesis; mitochondrial dysfunction; mitochondrial membrane potential; respiratory complexes

Mesh:

Substances:

Year:  2016        PMID: 26773315     DOI: 10.1111/jphp.12501

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

1.  Curcumin inhibits the development of non-small cell lung cancer by inhibiting autophagy and apoptosis.

Authors:  Aili Wang; Jinxiang Wang; Shuming Zhang; Hongxia Zhang; Zhenyang Xu; Xiaohui Li
Journal:  Exp Ther Med       Date:  2017-09-21       Impact factor: 2.447

Review 2.  Antioxidant dietary approach in treatment of fatty liver: New insights and updates.

Authors:  Alessandra Ferramosca; Mariangela Di Giacomo; Vincenzo Zara
Journal:  World J Gastroenterol       Date:  2017-06-21       Impact factor: 5.742

3.  Curcumin protects radiation-induced liver damage in rats through the NF-κB signaling pathway.

Authors:  Wei Li; Liangjun Jiang; Xianzhou Lu; Xianrong Liu; Mingjiong Ling
Journal:  BMC Complement Med Ther       Date:  2021-01-06

4.  First Evidence of a Protective Effect of Plant Bioactive Compounds against H2O2-Induced Aconitase Damage in Durum Wheat Mitochondria.

Authors:  Maura N Laus; Mario Soccio
Journal:  Antioxidants (Basel)       Date:  2020-12-10

5.  Curcumin Downregulates Phosphate Carrier and Protects against Doxorubicin Induced Cardiomyocyte Apoptosis.

Authors:  Lu Junkun; Chu Erfu; Hasahya Tony; Li Xin; K C Sudeep; Zhang Mingliang; Wang Yanqin; Qi XiangQian
Journal:  Biomed Res Int       Date:  2016-04-05       Impact factor: 3.411

Review 6.  Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives.

Authors:  Xiao-Yu Xu; Xiao Meng; Sha Li; Ren-You Gan; Ya Li; Hua-Bin Li
Journal:  Nutrients       Date:  2018-10-19       Impact factor: 5.717

Review 7.  Liver manifestations and complications in inflammatory bowel disease: A review.

Authors:  Rui Gaspar; Catarina Castelo Branco; Guilherme Macedo
Journal:  World J Hepatol       Date:  2021-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.